All Posts

Buying a California cannabis business involves far more than purchasing a license. This complete guide explains ownership changes, acquisition structures, due diligence, financing, regulatory approvals, inventory, real estate and closing.

Selling a cannabis business in California is far more complex than selling a traditional business. This comprehensive guide explains every stage of the M&A process, including valuation, confidential marketing, buyer qualification, due diligence, transaction structure, licensing considerations, and closing.

Federal cannabis reform is moving through both administrative and legislative channels. Whether marijuana is rescheduled or ultimately legalized, cannabis businesses should understand how these changes could affect valuations, mergers and acquisitions, capital formation, and long-term strategy.

Selling a vertically integrated cannabis business requires more than listing it for sale. Learn how experienced cannabis M&A advisors help owners maximize value through strategic positioning, valuation, confidential marketing, buyer qualification, and transaction execution.

Many cannabis business sales don't fail because of price. They fail because of preparation. Learn the most common reasons transactions fall apart and how owners can improve their chances of a successful closing

Distress doesn't always mean failure. In California's evolving cannabis industry, strategic M&A advisory can help operators preserve value, protect stakeholders, and create new opportunities before it's too late.

Not every cannabis business is worth the same. Learn the seven factors sophisticated buyers evaluate when valuing dispensaries, cultivation facilities, manufacturers, distribution businesses, and cannabis real estate in California.

Capital is returning. Enforcement is increasing. The California cannabis industry is maturing. For many operators, the next strategic decision may not be whether to sell—but whether to join a bigger platform.

Glass House, TerrAscend, Tilray, and Chicago Atlantic all made major announcements this week. Together, they tell a larger story about cannabis capital markets, M&A, and industry growth.

EBITDA may tell part of the story, but Free Cash Flow often tells the real story. Learn how sophisticated buyers value cannabis businesses.

Cannabis companies are beginning to reach major U.S. exchanges. Explore what cannabis stock uplisting could mean for investors, M&A, and industry growth.

The cannabis industry is shifting from speculation to execution. Discover why buyers increasingly prefer operating businesses and built infrastructure.

Three major themes emerged from Cannabis Capital Conference 2026: returning capital, hemp beverages, and California’s strategic advantage.

Could California become America's cannabis export hub? Explore how interstate commerce may reshape distribution, real estate, and cannabis M&A.

The world’s biggest sporting event is coming to California. Could cannabis businesses, retailers, and investors benefit from a surge in tourism?

Trulieve’s NYSE uplisting may become one of the most important cannabis capital markets milestones in recent years.

Retail portfolios, strategic acquisitions, real estate, and manufacturing are attracting increasing attention as cannabis enters a new phase.

The California cannabis industry may finally be entering a new phase. Here’s why consolidation, Schedule III, and capital markets matter.

Many cannabis disputes begin long before litigation. Learn practical strategies for managing expectations, communication, and conflict.

Historic TSA policy changes may allow medical marijuana on flights under new Schedule III guidance.